Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of net revenue from collaborative arrangements

Net revenue recognized under our GSK Agreements was as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
(In thousands)	2023			2022			2023			2022
Royalties    - RELVAR/BREO	$	54,454		$	59,326		$	105,337		$	115,090
Royalties    - ANORO		11,267			9,630			20,698			18,072
Royalties    - TRELEGY		—			42,720			—			72,029
Total royalties		65,721			111,676			126,035			205,191
Less: amortization of capitalized fees    paid		(3,456	)		(3,456	)		(6,912	)		(6,912	)
Total net royalty revenue	$	62,265		$	108,220		$	119,123		$	198,279